CN104256582A - 一种缓解女性更年期各种症状的保健品配方 - Google Patents
一种缓解女性更年期各种症状的保健品配方 Download PDFInfo
- Publication number
- CN104256582A CN104256582A CN201410450789.0A CN201410450789A CN104256582A CN 104256582 A CN104256582 A CN 104256582A CN 201410450789 A CN201410450789 A CN 201410450789A CN 104256582 A CN104256582 A CN 104256582A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- menopause
- product formula
- powder
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024891 symptom Diseases 0.000 title claims abstract description 19
- 230000036541 health Effects 0.000 title claims abstract description 18
- 230000009245 menopause Effects 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 22
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 22
- 102000008186 Collagen Human genes 0.000 claims abstract description 13
- 108010035532 Collagen Proteins 0.000 claims abstract description 13
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 12
- 235000021279 black bean Nutrition 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 11
- 235000019152 folic acid Nutrition 0.000 claims abstract description 11
- 239000011724 folic acid Substances 0.000 claims abstract description 11
- 229960000304 folic acid Drugs 0.000 claims abstract description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 11
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 11
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 11
- 239000011709 vitamin E Substances 0.000 claims abstract description 11
- 229940046009 vitamin E Drugs 0.000 claims abstract description 11
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 11
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 10
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 10
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 10
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 10
- 229920002472 Starch Polymers 0.000 claims abstract description 9
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 9
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 9
- 239000002002 slurry Substances 0.000 claims abstract description 9
- 235000019698 starch Nutrition 0.000 claims abstract description 9
- 239000008107 starch Substances 0.000 claims abstract description 9
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 9
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 7
- 229960003495 thiamine Drugs 0.000 claims abstract description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 7
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 7
- 244000046146 Pueraria lobata Species 0.000 claims description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 13
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 9
- 208000001132 Osteoporosis Diseases 0.000 abstract description 7
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 5
- 229920001436 collagen Polymers 0.000 abstract description 5
- 206010022437 insomnia Diseases 0.000 abstract description 5
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 230000002124 endocrine Effects 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 206010022998 Irritability Diseases 0.000 abstract description 3
- 206010037660 Pyrexia Diseases 0.000 abstract description 3
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 206010013954 Dysphoria Diseases 0.000 abstract 1
- 208000008454 Hyperhidrosis Diseases 0.000 abstract 1
- 206010029897 Obsessive thoughts Diseases 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- 238000011010 flushing procedure Methods 0.000 abstract 1
- 230000006996 mental state Effects 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000035900 sweating Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 241001247821 Ziziphus Species 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000040350 B family Human genes 0.000 description 5
- 108091072128 B family Proteins 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000001662 opsonic effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- YUKCLPPRYNXRAF-UHFFFAOYSA-N (+-)-16-Epiormosanin Natural products N1CCCCC1C1(CN2CCCCC22)C3NCCCC3CC2C1 YUKCLPPRYNXRAF-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 208000012219 Autonomic Nervous System disease Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010056610 Pseudoangina Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000004620 sleep latency Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000037322 slow-wave sleep Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及保健品领域,尤其是一种缓解女性更年期各种症状的保健品配方,其特征是:本配方按质量配比为:葛根提取物42~48%、黑豆粉16~22%、葡萄籽提取物11~16%、胶原蛋白粉7~11%、大枣粉7~11%、L-色氨酸0.14~0.18%、维生素C0.18~0.22%、维生素E0.013~0.017%、维生素B10.001~0.003%、维生素B60.001~0.003%、维生素B120.000004~0.000007%、叶酸0.0003~0.0006%,其余为淀粉浆,以上各组成成分之和为100%,本发明配方科学、安全、无毒副作用,能够有效的预防及改善更年期女性内分泌失调所引发的各种症状,缓解更年期潮热、潮红、出汗、烦躁、易怒、失眠、头痛、以及更年期骨质疏松、心血管并发症、妇科病等,减轻更年期综合症对更年期妇女精神状态及生活方面造成的不便和困扰。
Description
技术领域
本发明涉及保健品领域,尤其是一种缓解女性更年期各种症状的保健品配方。
背景技术
现代社会竞争激烈,生活压力加大,女性的心理负荷大大增加,再加上不良的生活规律、饮食习惯,据统计:我国约有20%的女性更年期提前了4~8年,女性更年斯有发病龄提前、发病率上升的趋势,极大的威胁着女性朋友们的健康与生活,研究表明:女性过了35岁以后,卵巢机能减退,内分泌紊乱,体内雌激素水平降低,是导致更年期产生的根本原因。更年期综合征最典型的症状是潮热、潮红、自汗。同时,自主神经系统功能紊乱并发神经心理症状,如烦躁、易怒、失眠、头痛等;泌尿生殖道症状,如尿频、尿急、夜尿增多,性欲降低等;心血管症状,如:胸闷、心慌、心悸等;以及骨质疏松症等常见症状。我国中医学认为,女性更年期综合征则是以“阴阳虚损、气血不足”为本,“肝郁或气滞或火旺”为标志出现的一系列症状,治疗应以“滋补肝肾、调理阴阳气血”为主。然而中医学的调养滋补法又见效缓慢,短时间内难以缓解更年期的痛苦症状。
发明内容
为了解决上述问题,本发明所提供一种缓解女性更年期各种症状的保健品配方,其技术方案如下:
所述的一种缓解女性更年期各种症状的保健品配方,其主要成分为葛根提取物及黑豆粉,其特征是:本配方按质量配比为:葛根提取物42~48%、黑豆粉16~22%、葡萄籽提取物11~16%、胶原蛋白粉7~11%、大枣粉7~11%、L-色氨酸0.14~0.18%、维生素C 0.18~0.22%、维生素E 0.013~0.017%、维生素B1 0.001~0.003%、维生素B6 0.001~0.003%、维生素B12 0.000004~0.000007%、叶酸0.0003~0.0006%,其余为淀粉浆,以上各组成成分之和为100%。
本发明的最佳组合配方按照质量配比是:葛根提取物45%、黑豆粉20%、葡萄籽提取物14%、胶原蛋白粉10%、大枣粉10%、L-色氨酸0.17%、维生素C 0.2%、维生素E 0.015%、维生素B1 0.002%、维生素B6 0.002%、维生素B12 0.000006%、叶酸0.0005%,其余为淀粉浆,以上各组成成分之和为100%。
所述的一种缓解女性更年期各种症状的保健品配方最终成型剂为颗粒剂、胶囊或片剂。
本配方的药理及功效总结如下:1)补充天然雌激素,双向调节内分泌:葛根和黑豆都是药食同源的原料,长期服用安全无副作用。它们富含的异黄酮,都是天然植物雌激素,结构与女性体内的雌激素相似,具有双向调节内分泌的作用,对低雌激素水平者,表现为雌激素样的替代补充作用,可调节激素下降引起的症状,如血脂升高、骨质疏松等;对高激素水平者,表现为抗雌激素样活性作用,可有助于防治乳腺癌、子宫内膜癌等;
2)防止骨质疏松:更年期女性雌激素降低导致骨钙流失严重,吸收困难,骨质疏松、骨折发病率大大增加。本品中添加的胶原蛋白,能够直接补充骨胶原,吸附钙质沉积,有效增加骨骼韧性,同时本品中添加的维生素C又可促进胶原蛋白的吸收利用率,有效防止骨质疏松。除此之外,胶原蛋白还具有增加皮肤组织细胞储水力,增强和维持肌肤弹性,强化肌肤韧性的作用,对更年期女性出现的肌肤问题有很好的调理改善作用;
3)清除自由基,抗氧化,抗衰老:葡萄籽富含高活性的天然抗氧化剂原花青素(OPC),其清除自由基、抗氧化能力是维生素E的50倍,维生素C的20倍。本品中将葡萄籽与维生素C和维生素E科学配比,更是大大增强了产品清除自由基、抗氧化、防衰老的作用。对更年期女性出现的各种肌肤问题,如:干燥、粗糙、毛孔粗大、皮肤暗黄、出现皱纹、各种色斑黄褐斑等都具有有效缓解作用。除此之外,葛根中含有的葛根素也同样具有抗氧化、抗衰老作用;
4)滋肝补肾,调理气血:黑豆作为药食同源的物质,不仅营养价值高,还具有许多保健功能。它味甘、性平、归脾、肾经,具有补肾益阴、明目健脾、补血安神、乌发黑发、延年益寿等作用。黑豆中蛋白含量高达48%以上,居豆类之首,具有“高蛋白、低热量”的特性,对更年期女性有很好的滋养调理作用。大枣不仅对身体虚弱有调理作用,亦有滋容养颜、补充气血之效,对贫血、心悸、健忘等症有明显疗效。更年期女性常食黑豆和大枣能够起到很好的营养保健作用;
5)舒缓神经、安神助眠:L-色氨酸能透过血脑屏障,在体内最终转化为5-羟色胺,对抑郁症、失眠症、高血压等有很好的调理作用。同时,它还是一种理想的安眠剂,它能使睡眠潜伏期缩短,慢波睡眠延长,觉醒时间减少,有效增加总睡眠量,对缓解更年期妇女睡眠障碍有很好的调理作用。除此之外,大枣、黑豆亦有补血安神的作用,对神经衰弱、失眠也有很好的缓解作用;
6)激活酶系统,调代谢:更年期女性的糖、脂肪代谢常常紊乱,容易产生高血糖、高血脂、高血压等,体态肥胖。B族维生素是人体内各种酶的催化剂,它们相互协作,是人体不可缺少的物质。B族维生素都是水溶性维生素,多余的完全排出体外,不在体内贮藏,随着年龄增长,人体从食物中获取B族维生素的能力减弱,且摄入种类单一,易缺乏B族维生素而产生疾病,更年期女性尤其容易缺乏。本品中B族维生素的联合运用,意在激活人体内各种酶,恢复机体各组织细胞功能,使机体精体力充沛;
7)降低心脑血管危险因子-同型半胱氨酸含量:同型半胱氨酸是继高血脂后心脑血管疾病又一新的独立致病危险因子,它是体内代谢分解蛋氨酸时的副产物,是一种强氧化剂,被认为是启动动脉血管内壁损伤,形成栓块的罪魁祸首。10%的冠心病与同型半胱氨酸水平偏高有关,轻~中度的高同型半胱氨酸血症可使心血管疾病死亡率升高4~6倍,它已成为冠心病等心脑血管疾病又一新致命因素,威胁着人们的健康;
维生素B6在氨基酸代谢过程中发挥着重要作用,它是控制血液中同型半胱氨酸水平的重要因素。维生素B12是活化叶酸代谢过程中的一种重要辅酶。同时科学的补充叶酸、维生素B6、维生素B12,可以使分解同型半胱氨酸的辅酶系统高效工作,能够有效缓解更年期产生的头痛、心悸、胸闷、心慌、假性心绞痛、轻度高血压、高血脂、高血糖等心脑血管症状。
本发明的有益效果是:本发明配方科学、安全、无毒副作用,能够有效的预防及改善更年期女性内分泌失调所引发的各种症状,缓解更年期潮热、潮红、出汗、烦躁、易怒、失眠、头痛、以及更年期骨质疏松、心血管并发症、妇科病等,减轻更年期综合症对更年期妇女精神状态及生活方面造成的不便和困扰。
具体实施方式
实施例1:本发明配方的使用规格为1g/袋,每日服用1-2次,每次服用1袋,按上述使用规格取葛根提取物47%、黑豆粉18%、葡萄籽提取物11%、胶原蛋白粉10%、大枣粉7%、L-色氨酸0.14%、维生素C 0.18%、维生素E0.013%、维生素B1 0.001%、维生素B6 0.001%、维生素B12 0.000004%、叶酸0.0003%,其余为淀粉浆,以上各组成成分之和为100%,充分搅匀后加水冲服即可。
实施例2:本发明配方的使用规格为1g/袋,每日服用1-2次,每次服用1袋,按上述使用规格取葛根提取物43%、黑豆粉17%、葡萄籽提取物12%、胶原蛋白粉8%、大枣粉8%、L-色氨酸0.15%、维生素C0.21%、维生素E0.016%、维生素B10.002%、维生素B60.002%、维生素B120.000006%、叶酸0.0004%,其余为淀粉浆,以上各组成成分之和为100%,充分搅匀后加水冲服即可。
实施例3:本发明配方的使用规格为1g/袋,每日服用1-2次,每次服用1袋,按上述使用规格取葛根提取物44%、黑豆粉18%、葡萄籽提取物13%、胶原蛋白粉9%、大枣粉9%、L-色氨酸0.16%、维生素C0.20%、维生素E0.015%、维生素B10.002%、维生素B6 0.002%、维生素B12 0.000005%、叶酸0.0004%,其余为淀粉浆,以上各组成成分之和为100%,充分搅匀后加水冲服即可。
实施例4:本发明配方的使用规格为1g/袋,每日服用1-2次,每次服用1袋,按上述使用规格取葛根提取物45%、黑豆粉19%、葡萄籽提取物14%、胶原蛋白粉10%、大枣粉10%、L-色氨酸0.17 %、维生素C 0.18%、维生素E 0.013%、维生素B1 0.001%、维生素B6 0.001%、维生素B 12 0.000004%、叶酸0.0003%,其余为淀粉浆,以上各组成成分之和为100%,充分搅匀后加水冲服即可。
Claims (2)
1.一种缓解女性更年期各种症状的保健品配方,其主要成分为葛根提取物及黑豆粉,其特征是:本配方按质量配比为:葛根提取物42~48%、黑豆粉16~22%、葡萄籽提取物11~16%、胶原蛋白粉7~11%、大枣粉7~11%、L-色氨酸0.14~0.18%、维生素C 0.18~0.22%、维生素E 0.013~0.017%、维生素B1 0.001~0.003%、维生素B6 0.001~0.003%、维生素B12 0.000004~0.000007%、叶酸0.0003~0.0006%,其余为淀粉浆,以上各组成成分之和为100%,该配方最终成型剂为颗粒剂、胶囊或片剂。
2.根据权利要求1所述的一种缓解女性更年期各种症状的保健品配方,其主要成分为葛根提取物及黑豆粉,其特征是:该配方最佳组合配方按照质量配比是:葛根提取物45%、黑豆粉20%、葡萄籽提取物14%、胶原蛋白粉10%、大枣粉10%、L-色氨酸0.17%、维生素C 0.2%、维生素E 0.015%、维生素B1 0.002%、维生素B6 0.002%、维生素B12 0.000006%、叶酸0.0005%,其余为淀粉浆,以上各组成成分之和为100%,本配方最终成型性状为颗粒剂、胶囊或片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410450789.0A CN104256582B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解女性更年期各种症状的保健品配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410450789.0A CN104256582B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解女性更年期各种症状的保健品配方 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104256582A true CN104256582A (zh) | 2015-01-07 |
CN104256582B CN104256582B (zh) | 2016-08-24 |
Family
ID=52148267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410450789.0A Active CN104256582B (zh) | 2014-09-05 | 2014-09-05 | 一种缓解女性更年期各种症状的保健品配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104256582B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105104937A (zh) * | 2015-09-23 | 2015-12-02 | 洛阳华以生物工程有限公司 | 一种调脂的保健品 |
CN111905061A (zh) * | 2020-07-02 | 2020-11-10 | 江苏康缘美域生物医药有限公司 | 一种养护女性卵巢抗衰老的组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361970A (zh) * | 2008-09-28 | 2009-02-11 | 成都自豪药业有限公司 | 一种具有美容保健作用的组合物及其用途 |
CN101986875A (zh) * | 2009-08-05 | 2011-03-23 | 潘健 | 一种延缓衰老的保健食品 |
CN102132918A (zh) * | 2010-12-30 | 2011-07-27 | 毕跃峰 | 一种具有养心安神作用的本草饮料及其制备方法 |
-
2014
- 2014-09-05 CN CN201410450789.0A patent/CN104256582B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361970A (zh) * | 2008-09-28 | 2009-02-11 | 成都自豪药业有限公司 | 一种具有美容保健作用的组合物及其用途 |
CN101986875A (zh) * | 2009-08-05 | 2011-03-23 | 潘健 | 一种延缓衰老的保健食品 |
CN102132918A (zh) * | 2010-12-30 | 2011-07-27 | 毕跃峰 | 一种具有养心安神作用的本草饮料及其制备方法 |
Non-Patent Citations (1)
Title |
---|
沈丕安: "《补益中药的临床运用》", 31 August 2008, article "葛根", pages: 479 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105104937A (zh) * | 2015-09-23 | 2015-12-02 | 洛阳华以生物工程有限公司 | 一种调脂的保健品 |
CN111905061A (zh) * | 2020-07-02 | 2020-11-10 | 江苏康缘美域生物医药有限公司 | 一种养护女性卵巢抗衰老的组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104256582B (zh) | 2016-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103266040B (zh) | 美容保健酒 | |
CN102640822B (zh) | 一种保健茶膏及其制备方法 | |
CN102965235B (zh) | 一种板栗养生酒 | |
CN102640829B (zh) | 具有改善心肌缺血功能的茶膏及其制备方法 | |
CN104187916B (zh) | 一种绿色环保饮品、食用酵素及其制备方法 | |
CN106562428A (zh) | 一种美颜美体膏滋及其制备方法 | |
CN109247571A (zh) | 一种抗衰防老养生保健食品及其制备方法 | |
CN102586066B (zh) | 一种保健酒及其制备方法 | |
CN102940219B (zh) | 一种土豆饼及其制作方法 | |
CN104824674A (zh) | 一种防治脱发的营养保健食品 | |
CN105495374A (zh) | 一种适用于孕妇的美白祛斑猪肚药膳及其制备方法 | |
CN102061247B (zh) | 一种复方参茸杜仲养生酒及其制备方法 | |
CN104256582A (zh) | 一种缓解女性更年期各种症状的保健品配方 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN104587425A (zh) | 一种驱寒膏的中药组成及制备方法 | |
CN100382832C (zh) | 一种用于改善女性更年期症状的保健食品 | |
CN103451067B (zh) | 抗疲劳保健药酒 | |
CN101352238A (zh) | 一种用于养颜美容的颗粒饮料及制作方法 | |
CN113117028A (zh) | 一种排毒养颜美白的中药组合物及制备方法 | |
CN103404667A (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN104687137A (zh) | 一种鹿茸健脑安神汤料的配方及生产方法 | |
CN108991198A (zh) | 一组调经暖宫防掉发的保健食品及药品的配方及其制备方法 | |
CN102763849A (zh) | 一种含纳米硒的保健品 | |
CN102048151B (zh) | 一种滋身养气功能的保健胶囊及其制备方法 | |
CN101991037A (zh) | 当归不老莓丸及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170329 Address after: 471000 Luoyang province high tech Zone Binhe Road, No. 3, building 22, Henan Patentee after: Henan Jiahe Kang biological food technology Co. Ltd. Address before: 471000 Henan city of Luoyang province high tech Development Zone Binhe Road No. 22 building 3 Patentee before: LUOYANG HUAYI BIOTECHNOLOGY CO., LTD. |